FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1893280351> ?p ?o ?g. }

• W1893280351 abstract "Background The progestogen component of oral contraceptives (OC) has undergone changes since it was first recognised that their chemical structures could influence the spectrum of minor adverse and beneficial effects. The major determinants of OCs are effectiveness, cycle control and common side effects. The rationale of this review is to provide a systematic comparison of OCs containing the progestogens currently in use worldwide. Objectives The objective of this review is to compare currently available low‐dose OCs containing ethinyl estradiol and different progestogens in terms of contraceptive effectiveness, cycle control, side effects and continuation rates. Search methods The Cochrane Controlled Trials Register, MEDLINE and EMBASE databases have been searched systematically. Relevant pharmaceutical companies and the authors of articles included in this review have been contacted for clarification. Selection criteria Randomised trials reporting clinical outcomes were considered for inclusion. We excluded studies comparing mono‐ with multiphasic pills, and crossover trials with trials in which the difference in total content of ethinyl estradiol between preparations exceeded 105 µg. Data collection and analysis The methodological quality and validity of studies were assessed based on the above‐mentioned inclusion criteria. Both application of inclusion criteria and data extraction were performed independently by the reviewers. Results are expressed as relative risk (RR) with 95% confidence interval (CI) using a random‐effects model. Main results Twenty‐two trials have been included in this review, thus generating 14 comparisons. Eighteen trials were sponsored by pharmaceutical companies and in only 5 cases had a blind trial been attempted. Most comparisons between different interventions included 1‐3 trials. There was less discontinuation with second‐ compared to first‐generation progestogens (RR: 0.79, 95% CI: 0.69‐0.91). Cycle control appears to be better when using second‐ compared to first‐generation progestogens for both mono‐ (RR: 0.69; 95% CI: 0.52‐0.91) and triphasic (RR: 0.61; 95% CI: 0.43‐0.85) preparations. Contraceptive effectiveness, spotting, breakthrough bleeding and the absence of withdrawal bleeding was similar when using GSD compared to LNG, although there was less intermenstrual bleeding in the GSD group (RR: 0.71, 95% CI: 0.55, 0.91). Drospirenone (DRSP) appeared to be similar to DSG. Authors' conclusions Based on data from one trial, compared to pills containing LNG, those containing GSD may be associated with less intermenstrual bleeding although they show similar patterns of spotting, breakthrough bleeding and the absence of withdrawal bleeds. GSD is also comparable to DSG. Regarding acceptability, all the indices show that third‐ and second‐generation progestogens are preferred over first‐generation preparations. Future research should focus on independently conducted, well‐designed randomised trials that compare third‐ and second‐generation progestogens in particular." @default.
• W1893280351 created "2016-06-24" @default.
• W1893280351 creator A5004260048 @default.
• W1893280351 creator A5036492908 @default.
• W1893280351 creator A5038983724 @default.
• W1893280351 creator A5084214657 @default.
• W1893280351 creator A5091610751 @default.
• W1893280351 date "2004-07-19" @default.
• W1893280351 modified "2023-10-15" @default.
• W1893280351 title "Progestogens in combined oral contraceptives for contraception" @default.
• W1893280351 cites W1687166224 @default.
• W1893280351 cites W1963726159 @default.
• W1893280351 cites W1968397374 @default.
• W1893280351 cites W1969363667 @default.
• W1893280351 cites W1970765377 @default.
• W1893280351 cites W1970895745 @default.
• W1893280351 cites W1973138908 @default.
• W1893280351 cites W1984706617 @default.
• W1893280351 cites W1990019422 @default.
• W1893280351 cites W1997433105 @default.
• W1893280351 cites W2001872404 @default.
• W1893280351 cites W2004419590 @default.
• W1893280351 cites W2004905352 @default.
• W1893280351 cites W2009836681 @default.
• W1893280351 cites W2016218315 @default.
• W1893280351 cites W2024614394 @default.
• W1893280351 cites W2032329028 @default.
• W1893280351 cites W2032430056 @default.
• W1893280351 cites W2034030112 @default.
• W1893280351 cites W2038008767 @default.
• W1893280351 cites W2041652355 @default.
• W1893280351 cites W2046614257 @default.
• W1893280351 cites W2052505805 @default.
• W1893280351 cites W2064462019 @default.
• W1893280351 cites W2066714784 @default.
• W1893280351 cites W2067352541 @default.
• W1893280351 cites W2080679039 @default.
• W1893280351 cites W2081525825 @default.
• W1893280351 cites W2087790510 @default.
• W1893280351 cites W2089900495 @default.
• W1893280351 cites W2090876132 @default.
• W1893280351 cites W2105637441 @default.
• W1893280351 cites W2106610083 @default.
• W1893280351 cites W2119919329 @default.
• W1893280351 cites W2129932159 @default.
• W1893280351 cites W2135818558 @default.
• W1893280351 cites W2143110821 @default.
• W1893280351 cites W2153030615 @default.
• W1893280351 cites W2153064410 @default.
• W1893280351 cites W2160147660 @default.
• W1893280351 cites W2161880547 @default.
• W1893280351 cites W4245334855 @default.
• W1893280351 cites W846496662 @default.
• W1893280351 doi "https://doi.org/10.1002/14651858.cd004861" @default.
• W1893280351 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15266546" @default.
• W1893280351 hasPublicationYear "2004" @default.
• W1893280351 type Work @default.
• W1893280351 sameAs 1893280351 @default.
• W1893280351 citedByCount "36" @default.
• W1893280351 countsByYear W18932803512012 @default.
• W1893280351 countsByYear W18932803512013 @default.
• W1893280351 countsByYear W18932803512014 @default.
• W1893280351 countsByYear W18932803512015 @default.
• W1893280351 countsByYear W18932803512016 @default.
• W1893280351 countsByYear W18932803512018 @default.
• W1893280351 crossrefType "reference-entry" @default.
• W1893280351 hasAuthorship W1893280351A5004260048 @default.
• W1893280351 hasAuthorship W1893280351A5036492908 @default.
• W1893280351 hasAuthorship W1893280351A5038983724 @default.
• W1893280351 hasAuthorship W1893280351A5084214657 @default.
• W1893280351 hasAuthorship W1893280351A5091610751 @default.
• W1893280351 hasConcept C118552586 @default.
• W1893280351 hasConcept C126322002 @default.
• W1893280351 hasConcept C142724271 @default.
• W1893280351 hasConcept C17744445 @default.
• W1893280351 hasConcept C197934379 @default.
• W1893280351 hasConcept C199539241 @default.
• W1893280351 hasConcept C204787440 @default.
• W1893280351 hasConcept C27081682 @default.
• W1893280351 hasConcept C27415008 @default.
• W1893280351 hasConcept C2777164284 @default.
• W1893280351 hasConcept C2777466982 @default.
• W1893280351 hasConcept C2779076696 @default.
• W1893280351 hasConcept C2779441745 @default.
• W1893280351 hasConcept C2779473830 @default.
• W1893280351 hasConcept C2780330700 @default.
• W1893280351 hasConcept C2780572241 @default.
• W1893280351 hasConcept C2908647359 @default.
• W1893280351 hasConcept C29456083 @default.
• W1893280351 hasConcept C2986817661 @default.
• W1893280351 hasConcept C44249647 @default.
• W1893280351 hasConcept C535046627 @default.
• W1893280351 hasConcept C71924100 @default.
• W1893280351 hasConcept C81603835 @default.
• W1893280351 hasConcept C82789193 @default.
• W1893280351 hasConcept C95190672 @default.
• W1893280351 hasConcept C98274493 @default.
• W1893280351 hasConcept C99454951 @default.
• W1893280351 hasConceptScore W1893280351C118552586 @default.
• W1893280351 hasConceptScore W1893280351C126322002 @default.

• next